WTCZF yields 11111.11% · PFE yields 6.13%● Live data
📍 WTCZF pulled ahead of the other in Year 1
Combined, WTCZF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of WTCZF + PFE for your $10,000?
Copper Lake Resources Ltd. engages in the exploration, evaluation, and development of mineral properties in Canada. It explores for copper, zinc, silver, gold, nickel, cobalt, platinum, and palladium mineral properties. The company primarily focuses on the exploration and development of the Marshall Lake property that includes 43 mineral claims with an area of 8,864 hectares, as well as 89 mining leases with an area of 1,566.17 hectares for a total land position of 10,430.17 hectares situated north of Thunder Bay, Ontario; the Norton Lake property that consists of 32 claims covering approximately 8,800 hectares located to the north of Thunder Bay, Ontario; and holds 25% interest in Centrefire Redhat gold-copper property. The company was formerly known as White Tiger Mining Corp. and changed its name to Copper Lake Resources Ltd. in September 2014. Copper Lake Resources Ltd. was incorporated in 1984 and is headquartered in Toronto, Canada.
Full WTCZF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.